New strategy to attack aggressive brain cancer shows promise
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles
Children are evacuated from school 'during an exam' after threat made via email
Children have been evacuated from a school with Year 11 students told to leave mid-exam after a thre2024-05-21Christopher Luxon arrives in Wellington ahead of potential coalition announcement
Christopher Luxon arrives at Wellington Airport. Photo: Ashleigh McCaull / RNZ2024-05-21Whale song mystery solved by scientists
By Helen Briggs and Victoria Gill for BBC NewsA humpback whale. Photo: konart/123RF2024-05-21Christopher Luxon and business leaders to travel to South East Asia on trade, diplomatic mission
Prime Minister Christopher Luxon speaking at post-cab Photo: RNZ / Angus Dreaver2024-05-21Ricky Stenhouse punching Kyle Busch could lead to suspension
NORTH WILKESBORO, N.C. (AP) — Ricky Stenhouse Jr. threw a right hook at Kyle Busch, and suddenly, an2024-05-21Some Auckland train services cancelled
Photo: RNZ / Nick Monro2024-05-21
atest comment